Indeed, reducing senescence either genetically or with senolytic agents in obese mouse models with T2D restores adipogenesis in sWAT and alleviates metabolic and AT dysfunction (i.e. reduction of inflammation and enhanced insulin sensitivity) [50,51]. The gene discussed is INS; the disease is type 2 diabetes mellitus.